{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:59:00Z","timestamp":1792079940008,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020JJ5908"],"award-info":[{"award-number":["2020JJ5908"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003239"],"award-info":[{"award-number":["82003239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Radioresistance emerges as the major obstacle to nasopharyngeal carcinoma (NPC) treatment, further understanding of underlying mechanisms is necessary to overcome the radioresistance and improve the therapeutic effect. In this study, we first identified a candidate radioresistant-related gene <jats:italic>LUC7L2<\/jats:italic> via CRISPR\/Cas9 high-throughput screening and quantitative proteomic approach. Overexpression of LUC7L2 in NPC cells promoted cell viability following exposure to ionizing radiation (IR), while knockdown of LUC7L2 significantly slowed down the DNA replication and impaired cell survival, sensitized NPC-radioresistant cells to IR. Using immunoprecipitation assay, we found SQSTM1, an autophagy receptor, was a potential binding partner of LUC7L2. Down-regulation of LUC7L2 in NPC-radioresistant cells led to reduction of SQSTM1 expression and enhancement of autophagy level. Furthermore, LUC7L2 knockdown in combination with autophagy inhibitor, chloroquine (CQ), resulted in more NPC-radioresistant cell death. Besides, LUC7L2 was obviously distributed in NPC tissues, and high LUC7L2 expression correlated with shorter survival in NPC patients. Our data suggest that LUC7L2 plays a huge part in regulating radioresistance of NPC cells, and serves as a promising therapeutic target in re-sensitizing NPC to radiotherapy.<\/jats:p>","DOI":"10.1038\/s41420-021-00783-8","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T14:03:14Z","timestamp":1639490594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CRISPR\/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Lin","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangfang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-0605","authenticated-orcid":false,"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"783_CR1","doi-asserted-by":"crossref","unstructured":"Guo R, Mao YP, Tang LL, Chen L, Sun P, Ma J. The evolution of nasopharyngeal carcinoma staging. Brit J Radiol. 2019;92:20190244.","DOI":"10.1259\/bjr.20190244"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-030-22254-3_2","volume":"1164","author":"HM Lee","year":"2019","unstructured":"Lee HM, Okuda KS, Gonzalez FE, Patel V. Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol. 2019;1164:11\u201334.","journal-title":"Adv Exp Med Biol"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/cells8091105","volume":"8","author":"W Kim","year":"2019","unstructured":"Kim W, Lee S, Seo D, Kim D, Kim K, Kim E, et al. Cellular stress responses in radiotherapy. Cells. 2019;8:1105.","journal-title":"Cells"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.7150\/jca.39354","volume":"11","author":"YT Zhan","year":"2020","unstructured":"Zhan YT, Fan SQ. Multiple mechanisms involving in radioresistance of nasopharyngeal carcinoma. J Cancer. 2020;11:4193\u2013204.","journal-title":"J Cancer"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/1535-7163.MCT-06-0801","volume":"6","author":"JTC Chang","year":"2007","unstructured":"Chang JTC, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol. Cancer Ther. 2007;6:2271\u20139.","journal-title":"Mol. Cancer Ther"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-09-4099","volume":"70","author":"XP Feng","year":"2010","unstructured":"Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang PF, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 2010;70:3450\u201362.","journal-title":"Cancer Res"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fonc.2018.00548","volume":"8","author":"ZZ Li","year":"2018","unstructured":"Li ZZ, Li N, Shen LF, Fu J. Quantitative proteomic analysis identifies MAPK15 as a potential regulator of radioresistance in nasopharyngeal carcinoma cells. Front Oncol. 2018;8:548.","journal-title":"Front Oncol"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1101\/gad.13.18.2425","volume":"13","author":"P Fortes","year":"1999","unstructured":"Fortes P, Bilbao-Cortes D, Fornerod M, Rigaut G, Raymond W, Seraphin B, et al. Luc7p, a novel yeast U1 snRNP protein with role in 5 \u2018 splice site recognition. Gene Dev. 1999;13:2425\u201338.","journal-title":"Gene Dev"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/hmg\/ddm206","volume":"16","author":"VM Howell","year":"2007","unstructured":"Howell VM, Jones JM, Bergren SK, Li L, Billi AC, Avenarius MR, et al. Evidence for a direct role of the disease modifier SCNM1 in splicing. Hum Mol Genet. 2007;16:2506\u201316.","journal-title":"Hum Mol Genet"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/cancers11121844","volume":"11","author":"V Visconte","year":"2019","unstructured":"Visconte V, Nakashima MO, Rogers HJ. Mutations in splicing factor genes in myeloid malignancies: significance and impact on clinical features. Cancers. 2019;11:1844.","journal-title":"Cancers"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13014-017-0795-y","volume":"12","author":"SY Tam","year":"2017","unstructured":"Tam SY, Wu VWC, Law HKW. Influence of autophagy on the efficacy of radiotherapy. Radiat Oncol. 2017;12:57.","journal-title":"Radiat Oncol"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2020.01.037","volume":"483","author":"H Chen","year":"2020","unstructured":"Chen H, Yao XJ, Di XK, Zhang YX, Zhu HC, Liu S, et al. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma. Cancer Lett. 2020;483:114\u201326.","journal-title":"Cancer Lett"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10495-018-1480-9","volume":"23","author":"MA Taylor","year":"2018","unstructured":"Taylor MA, Das BC, Ray SK. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis. 2018;23:563\u201375.","journal-title":"Apoptosis"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.2147\/CMAR.S176536","volume":"10","author":"ZG Liang","year":"2018","unstructured":"Liang ZG, Lin GX, Yu BB, Su F, Li L, Qu S, et al. The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R. Cancer Manag Res. 2018;10:4125\u201334.","journal-title":"Cancer Manag Res"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1111\/jcmm.14394","volume":"23","author":"QC Jing","year":"2019","unstructured":"Jing QC, Li G, Chen XY, Liu C, Lu SH, Zheng H, et al. Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck. J Cell Mol Med. 2019;23:4711\u201322.","journal-title":"J Cell Mol Med"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2018.09.020","volume":"505","author":"ZZ Li","year":"2018","unstructured":"Li ZZ, Fu J, Li N, Shen LF. Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2018;505:274\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1002\/cam4.1614","volume":"7","author":"X Zhu","year":"2018","unstructured":"Zhu X, Wang Y, Tan L, Fu X. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy. Cancer Med. 2018;7:3812\u20139.","journal-title":"Cancer Med"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1172\/JCI120518","volume":"128","author":"DX Su","year":"2018","unstructured":"Su DX, Ma S, Shan L, Wang Y, Wang YJ, Cao C, et al. Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. J Clin Invest. 2018;128:4280\u201396.","journal-title":"J Clin Invest"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.3390\/ijms22083965","volume":"22","author":"M Ito","year":"2021","unstructured":"Ito M, Yurube T, Kanda Y, Kakiuchi Y, Takeoka Y, Takada T, et al. Inhibition of autophagy at different stages by ATG5 knockdown and chloroquine supplementation enhances consistent human disc cellular apoptosis and senescence induction rather than extracellular matrix catabolism. Int J Mol Sci. 2021;22:3965.","journal-title":"Int J Mol Sci"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/auto.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542\u20135.","journal-title":"Autophagy"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat. Rev. Cancer. 2017;17:528\u201342.","journal-title":"Nat. Rev. Cancer"},{"key":"783_CR24","first-page":"105358","volume":"2015","author":"T Janvilisri","year":"2015","unstructured":"Janvilisri T, Suzuki H, Scaria J, Chen JW, Charoensawan V. High-throughput screening for biomarker discovery. Dis Markers. 2015;2015:105358.","journal-title":"Dis Markers"},{"key":"783_CR25","doi-asserted-by":"crossref","unstructured":"Cifani P, Kentsis A. Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease. Proteomics. 2017;17:10.1002\/pmic.201600079.","DOI":"10.1101\/072215"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s12272-018-1029-z","volume":"41","author":"J Kweon","year":"2018","unstructured":"Kweon J, Kim Y. High-throughput genetic screens using CRISPR-Cas9 system. Arch. Pharm. Res. 2018;41:875\u201384.","journal-title":"Arch. Pharm. Res"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1038\/bcj.2013.16","volume":"3","author":"H Singh","year":"2013","unstructured":"Singh H, Lane AA, Correll M, Przychodzen B, Sykes DB, Stone RM, et al. Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies. Blood Cancer J. 2013;3:e117.","journal-title":"Blood Cancer J"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41419-021-03639-2","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Zhou ZA, Peng XZ, Tao XX, Zhou PJ, Zhang K, et al. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma. Cell Death Dis. 2021;12:344.","journal-title":"Cell Death Dis"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"e0166766","DOI":"10.1371\/journal.pone.0166766","volume":"11","author":"A Makowska","year":"2016","unstructured":"Makowska A, Eble M, Prescher K, Hoss M, Kontny U. Chloroquine sensitizes nasopharyngeal carcinoma cells but not nasoepithelial cells to irradiation by blocking autophagy. PLoS ONE. 2016;11:e0166766.","journal-title":"PLoS ONE"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10147-019-01462-6","volume":"24","author":"N Hosono","year":"2019","unstructured":"Hosono N. Genetic abnormalities and pathophysiology of MDS. Int J Clin Oncol. 2019;24:885\u201392.","journal-title":"Int J Clin Oncol"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/leu.2014.25","volume":"28","author":"N Hosono","year":"2014","unstructured":"Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, et al. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia. 2014;28:1348\u201351.","journal-title":"Leukemia"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.2147\/CMAR.S184689","volume":"10","author":"ZZ Li","year":"2018","unstructured":"Li ZZ, Li N, Shen LF. MAP2K6 is associated with radiation resistance and adverse prognosis for locally advanced nasopharyngeal carcinoma patients. Cancer Manag Res. 2018;10:6905\u201312.","journal-title":"Cancer Manag Res"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00783-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:59:35Z","timestamp":1669975175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-021-00783-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1038\/s41420-021-00783-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A human tissue microarray containing 132 NPC patient tissue samples and the associated clinicopathological information were provided by Shanghai OUTDO Biotech Co. (Shanghai, China). The IHC experiment was approved by Committee on the Shanghai Outdo Biotech Company (Project number: T20-1472).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"392"}}